Targeted therapeutics to stop & reverse Multiple Sclerosis
Transforming life through groundbreaking research and development
Live Well with MS
NeuOrphan: a pioneer in Life Sciences and Biotechnology
We are dedicated to developing a novel drug to treat individuals living with multiple sclerosis (MS) and other neurological disorders. Our drug, currently in the preclinical stage of development, aims to protect the central nervous system from inflammatory damage and promote repair through remyelination, addressing the unmet medical need in patients with MS progression.
- Developing DioprotectomeTM as a combination therapy used with existing treatments to combat MS
- DioprotectomeTM is our solution to MS and has exhibited the potential to protect nerve fibres from immune damage and repair them.
A Growing Cost to society
MS patients with relapsing-remitting MS(RRMS)
Risk of developing MS with a first-degree reletive with MS
Woman diagnosed in the prime of their lives
MS patients that will worsen over time even with standard of care
Our Vision
Our vision is to accelerate groundbreaking research and innovative treatments for MS, empowering individuals to live healthier, fuller lives.
Our Misson
Our mission is to advance innovative research to develop treatments for neurological disorders, offering hope and improved quality of life for millions of people affected worldwide.